The Immunoassay Handbook : theory and applications of ligand binding, ELISA and related techniques

This handbook encompasses a wide range of methods and gives an insight into the latest developments and applications in clinical and veterinary practice and in pharmaceutical and life science research

Сохранить в:
Библиографические подробности
Другие авторы: Wild, David (Редактор)
Формат: Livre numérique
Язык:Anglais
Опубликовано: [Amsterdam] : Elsevier B. V. 2013, cop. 2013.
Редактирование:4th edition.
Предметы:
Online-ссылка:Accès Université Orléans et IFPM
Примечание: Notice modifiée d après la consultation du 2017-03-15
Titre provenant de la page de titre du document numérique
Version électronique de l'édition de Oxford : Elsevier, 2013
La pagination de l'édition imprimée correspondante est de 1013 p.
Cyberlibris (ScholarVox) corpus Santé
Type of computer file: Présentation en 84 fichiers correspondant aux différents chapitres, parties liminaires et index. Formats HTML, PDF, EPUB et Mobipocket
Autres localisations: Voir dans le Sudoc
Variante du titre:Theory and applications of ligand binding, ELISA and related techniques
Edition sous un autre format:• The immunoassay handbook, theory and applications of ligand binding, ELISA and related techniques, edited by David Wild, 4th ed., Amsterdam, Elsevier, 2013, 1 vol. (XIX-1013 p.), 978-0-08-097037-0
Оглавление:
  • Part 1: Immunoassay Fundamentals
  • Chapter 1.1 - How to Use This Book
  • Chapter 1.2 - Immunoassay for Beginners
  • Chapter 1.3 - Immunoassay Performance Measures
  • Part 2: Immunoassay Configurations
  • Chapter 2.1 - Principles of Competitive and Immunometric Assays (Including ELISA)1
  • Chapter 2.2 - Non-competitive Immunoassays for Small Molecules the Anti-complex and Selective Antibody Systems
  • Chapter 2.3 - Homogeneous Immunoassays
  • Chapter 2.4 - Lateral Flow Immunoassay Systems: Evolution from the Current State of the Art to the Next Generation of Highly Sensitive, Quantitative Rapid Assays
  • Chapter 2.5 - Ambient Analyte Assay
  • Chapter 2.6 - Free Analyte Immunoassay
  • Chapter 2.7 - Qualitative Immunoassay Features and Design
  • Chapter 2.8 - Detection of Antibodies Relevant to Infectious Disease
  • Chapter 2.9 - Microsphere-Based Multiplex Immunoassays: Development and Applications Using Luminex® xMAP® Technology
  • Chapter 2.10 - Lab-on-a-Chip, Micro- and Nanoscale Immunoassay Systems, and Microarrays
  • Chapter 2.11 - Immunological Biosensors
  • Chapter 2.12 - Surface Plasmon Resonance in Binding Site, Kinetic, and Concentration Analyses
  • Chapter 2.13 - Measurement of Single Protein Molecules Using Digital ELISA
  • Part 3: Immunoassay Components
  • Chapter 3.1 - Antibodies
  • Chapter 3.2 - Signal Generation and Detection Systems (Excluding Homogeneous Assays)
  • Chapter 3.3 - Separation Systems
  • Chapter 3.4 - Conjugation Methods
  • Chapter 3.5 - Standardization and Calibration
  • Chapter 3.6 - Calibration Curve Fitting
  • Part 4: Related Techniques
  • Chapter 4.1 - The Foundations of Immunochemistry
  • Chapter 4.2 - Immunohistochemistry and Immunocytochemistry
  • Part 5: Immunoassay Development
  • Chapter 5.1 - Practical Guide to ELISA Development
  • Chapter 5.2 - Method Evaluation A Practical Guide
  • Chapter 5.3 - Interferences in Immunoassay
  • Chapter 5.4 - Immunoassay Development in the In Vitro Diagnostic Industry
  • Part 6: Immunoassay Implementation
  • Chapter 6.1 - Sample Collection, Including Participant Preparation and Sample Handling
  • Chapter 6.2 - Quality Assurance
  • Chapter 6.3 - Point-of-Care Testing
  • Chapter 6.4 - Choosing an Automated Immunoassay System
  • Chapter 6.5 - Immunoassay Troubleshooting Guide
  • Part 7: Immunoassay Product Technology
  • Chapter 7.1 - Introduction to Immunoassay Product Technology in Clinical Diagnostic Testing
  • Chapter 7.2 - Market Trends
  • Chapter 7.3 - Lateral Flow and Consumer Diagnostics
  • Chapter 7.4 - Consumer Diagnostics Clearblue Pregnancy and Fertility Testing
  • Chapter 7.5 - The Triage® System
  • Chapter 7.6 - Stratus® CS Acute Care STAT Fluorometric Analyzer
  • Chapter 7.7 - IMx®1
  • Chapter 7.8 - AxSYM®
  • Chapter 7.9 - Abbott ARCHITECT® Family of Analyzers
  • Chapter 7.10 - ADVIA Centaur® XP
  • Chapter 7.11 - IMMULITE® and IMMULITE 1000
  • Chapter 7.12 - IMMULITE® 2000 and IMMULITE 2000 XPi
  • Chapter 7.13 - VITROS® ECiQ Immunodiagnostic System, VITROS® 3600 Immunodiagnostic System, and VITROS® 5600 Integrated System
  • Chapter 7.14 - VITROS® Immuno-Rate and MicroTip Assays
  • Chapter 7.15 - Access 2
  • Chapter 7.16 - DxI 600 and DxI 800
  • Chapter 7.17 - Elecsys® Immunoassay Systems
  • Chapter 7.18 - PRISM
  • Chapter 7.19 - Phadia Laboratory Systems
  • Part 8: Immunoassay Applications Other Than Clinical Chemistry
  • Chapter 8.1 - Immunoassay Applications in Veterinary Diagnostics
  • Chapter 8.2 - Ligand Binding Assays in Drug Development
  • Part 9: Immunoassay Clinical Applications (Human)
  • Chapter 9.1 - Clinical Concepts
  • Chapter 9.2 - Thyroid
  • Chapter 9.3 - The Adrenal Cortex
  • Chapter 9.4 - Bone and Calcium Metabolism
  • Chapter 9.5 - Infertility
  • Chapter 9.6 - In Vitro Fertilization and Embryo Transfer (IVF-ET)
  • Chapter 9.7 - Hirsutism and Virilization in the Female
  • Chapter 9.8 - Pregnancy
  • Chapter 9.9 - Growth and Growth Hormone Deficiency
  • Chapter 9.10 - Diabetes Mellitus
  • Chapter 9.11 - Hematology
  • Chapter 9.12 - Cardiac Markers
  • Chapter 9.13 - Cancer Markers
  • Chapter 9.14 - Allergy
  • Chapter 9.15 - Autoimmune Disease
  • Chapter 9.16 - Gastrointestinal Tract
  • Chapter 9.17 - Hepatitis
  • Chapter 9.18 - HIV-1 and HIV-2: Causative Agents of AIDS
  • Chapter 9.19 - Viral Diseases1
  • Chapter 9.20 - Bacterial Diseases1
  • Chapter 9.21 - Parasites and Fungi
  • Chapter 9.22 - Therapeutic Drug Monitoring (TDM)
  • Chapter 9.23 - Drugs of Abuse